Key Application Scenarios
Glycemic control in Type 2 diabetes: Indicated for adult patients with inadequate glycemic control on metformin or sulfonylureas alone; used as part of a combination therapy regimen, it can reduce HbA1c levels by 1–1.5%.
Cardiovascular protection: FDA-approved to reduce the risk of major adverse cardiovascular events (MACE) in adults with Type 2 diabetes and established cardiovascular disease; the LEADER trial demonstrated a reduction in the risk of cardiovascular death.
Chronic weight management: Indicated for adults with a BMI ≥30 (obesity) or a BMI ≥27 with at least one weight-related comorbidity; the recommended dosage is 3.0 mg/day, resulting in an average weight loss of approximately 8.4 kg.
Adolescent obesity: FDA-approved in 2020 for the treatment of obesity in adolescents aged ≥12 years weighing ≥60 kg.
Non-alcoholic steatohepatitis (NASH): AACE guidelines suggest it as an alternative to semaglutide for NASH patients with a BMI >27 or comorbid Type 2 diabetes.
Sports and physique management
As a non-steroidal GLP-1 receptor agonist, it is used to assist with body fat management, weight loss and body shaping, and metabolic optimization.
Benefits in bodybuilding
The value of Liraglutide in bodybuilding and physique management is primarily reflected in the following areas:
Highly effective fat loss: By activating GLP-1 receptors in the hypothalamic appetite-regulating centers, it significantly increases satiety and reduces caloric intake; simultaneously, it delays gastric emptying, effectively lowering body fat percentage. Clinical trials show an average weight loss of approximately 8.4 kg.
Precise Body Fat Control: For bodybuilders requiring strict body fat control during competition preparation, Liraglutide offers a non-steroidal method of body fat management, facilitating fat loss without reliance on traditional "cutting" drugs.
Improved Insulin Sensitivity: It promotes insulin secretion via a glucose-dependent mechanism and alleviates systemic insulin resistance; this helps optimize nutrient partitioning, directing ingested carbohydrates toward glycogen storage rather than conversion into fat.
Preservation of Muscle Mass: Research indicates that Liraglutide protects skeletal muscle from obesity-induced atrophy via the SIRT1 pathway; when combined with resistance training, it effectively maintains lean body mass.
Synergistic Effects with Exercise: A study by the University of Copenhagen published in the *New England Journal of Medicine* confirmed that a regimen combining Liraglutide with exercise is approximately twice as effective as monotherapy in reducing body weight and body fat percentage, while also improving cardiopulmonary function and metabolic health.
Comprehensive Metabolic Improvement: It can lower systolic blood pressure by approximately 7 mmHg, improve HbA1c levels, and optimize overall metabolic status, providing a superior physiological foundation for high-intensity training.
Storage and Usage Instructions
Storage Conditions
Unopened: Store refrigerated at 2–8°C, protected from light. Do not freeze; the medication becomes ineffective if frozen. Usage Instructions
Post-first use: Store at room temperature (below 30°C) or refrigerated (2–8°C); use within 30 days.
Precautions: Avoid direct sunlight and high temperatures; replace the pen cap after each use and remove the needle for storage to prevent contamination and leakage.
Transport requirements: Requires a cold chain throughout the entire transport process.
Administration
Route: Subcutaneous injection (SC) only; do not administer intravenously or intramuscularly. Injection sites include the abdomen, thigh, or upper arm.
Timing: Inject once daily at a fixed time; administration is independent of meal times.
Dose escalation schedule (for blood glucose control):
Week 1: 0.6 mg/day (acclimatization period to minimize gastrointestinal side effects).
From Week 2: Increase to 1.2 mg/day.
If glycemic control is inadequate and tolerability is good: Increase to 1.8 mg/day (maximum dose).
Dose escalation schedule (for weight loss):
Week 1: 0.6 mg/day.
Increase by 0.6 mg weekly, gradually escalating to 3.0 mg/day (recommended maintenance dose).
Injection site rotation: Rotate sites for each injection; the new site should be at least 2.5 cm away from the previous one to prevent localized lipoatrophy.
Missed dose: A missed dose may be administered within 12 hours; if more than 12 hours have passed, skip the dose and resume the normal schedule the next day-do not double the dose.
Why Choose Us
In the increasingly competitive Liraglutide market, selecting a reliable supplier is crucial. Our core strengths lie in the following areas:
Direct Supply from the Manufacturer
As the original manufacturer, we eliminate intermediaries, offering customers more competitive prices and direct communication channels. We maintain full control over the entire process, from raw material procurement to the release of finished products.
Professional Production Facilities
We utilize production facilities that meet international standards and employ advanced peptide synthesis and purification technologies to ensure batch-to-batch consistency. Production strictly adheres to quality management protocols, ensuring full traceability at every stage.
Reliable Supply Guarantee
Backed by robust production planning and inventory management systems, we ensure timely order fulfillment. We provide stable supply chain support for both routine procurement and urgent requirements. High Purity
Product purity is the core indicator of Liraglutide quality. We employ precision testing methods, such as High-Performance Liquid Chromatography (HPLC), to conduct rigorous quality control on every batch, ensuring purity levels that lead the industry.
Consistent and Reliable Quality
We have established a comprehensive quality control system covering everything from raw material selection to the release of finished products. Each batch undergoes strict inspection to ensure all specifications meet required standards.
Worry-Free After-Sales Service
We provide professional technical support and after-sales service. Should any product-related issues arise, you will receive prompt responses and solutions, ensuring a worry-free purchasing experience.
Choosing us means choosing quality and reliability.
FAQ
Q: Where are your products manufactured?
A: Our products originate from Shenzhen, China.
Q: What is the minimum order quantity (MOQ)?
A: The minimum order quantity is 10 bottles/sets.
Q: How soon do you ship?
A: Orders for in-stock items are shipped within 24 hours.
Q: What purity levels do you offer?
A: Standard purity is 99%.
Q: Which shipping carriers do you use?
A: Options include FedEx, DHL, UPS, and postal services.
Q: How long does shipping take?
A: Approximately 10–15 days.
Q: Can you provide COA and HPLC test reports?
A: Yes, these are available; all goods undergo professional testing before shipment.
Q: Do you offer OEM/private labeling services?
A: Yes, OEM services are available, subject to minimum order quantity requirements.
Q: How is after-sales service handled?
A: If a quality issue caused by our production is confirmed after the customer receives the goods, we offer free replacement or a refund. We uphold a pragmatic and responsible service philosophy, actively responding to and properly resolving issues without evasion or excuses, fully safeguarding our customers' interests.
Q: What payment methods do you accept?
A: We accept bank transfers, Bitcoin, TransferWise, and Xoom.
Hot Tags: liraglutide 2mg/vial is used for weight loss treatment in obese or overweight adults. cas: 204656-20-2, China liraglutide 2mg/vial is used for weight loss treatment in obese or overweight adults. cas: 204656-20-2 manufacturers, suppliers, factory
